Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

12,454.00p

Change Today:

18.00p
52 Week High: 12,750.00
52 Week Low: 9,667.00

Currency: UK Pounds
Shares Issued: 1,550.70m
Volume: 2,710,473

Market Cap: £193,124m
RiskGrade: 123

AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

1 Day Chart

6 Month Chart

More AstraZeneca charts

Digital Look Charts Sponsored by Barclays Stockbrokers

AstraZeneca Financials

	Latest	F'cast
Div Yield	2.1%	0.0%
Div Cover	2.6	2.8
Op Mrgn	18.5%	31.8%
ROCE	60.7%

	Latest	F'cast
P/E	18.3	18.4
PEG	1.4	1.8
Pr/Revenue	4.3	3.3
Pr/Book	5.7

	Latest	F'cast
Revenue	18.0%	-20.0%
PBT	26.0%	58.5%
EPS	13.1%	10.5%
DPS	6.9%	n/a

AstraZeneca Fundamentals

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-20	26,617.00	3,916.00	244.00¢	40.3	0.3	+137%	280.00¢	2.8%
31-Dec-21	37,417.00	(265.00)	8.00¢	1,458.1	n/a	-97%	287.00¢	2.5%
31-Dec-22	44,351.00	2,501.00	212.00¢	71.1	0.0	+2,550%	290.00¢	1.9%
31-Dec-23	45,811.00	6,899.00	726.00¢	19.6	0.1	+242%	290.00¢	2.0%
31-Dec-24	54,073.00	8,691.00	821.00¢	17.1	1.3	+13%	310.00¢	2.2%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AstraZeneca Forecasts

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-25	58,172.74	18,518.58	676.49p	18.4	1.8	+10%	241.78p	0.0%
31-Dec-26	61,673.93	20,647.28	767.28p	16.2	1.2	+13%	254.16p	0.0%
31-Dec-27	65,183.88	22,711.73	852.19p	14.6	1.3	+11%	266.14p	0.0%

AstraZeneca forecasts

AstraZeneca Company Announcements

Total Voting Rights	01-Oct-2025	15:00	RNS
Enhertu improved IDFS in early BC in DB-05	29-Sep-2025	07:30	RNS
AZN harmonises listing structure	29-Sep-2025	07:00	RNS

More astrazeneca company announcements

AstraZeneca ShareCast News

Trump's MFN deal with Pfizer could be bellwether...	01-Oct-2025	ShareCast
AstraZeneca to list in New York, retain London l...	29-Sep-2025	ShareCast
Trump to impose tariffs of 100% on branded drug ...	26-Sep-2025	ShareCast

More AstraZeneca ShareCast news

AstraZeneca Top Newspaper Links

AstraZeneca plans direct US listing in blow to L...	29-Sep-2025	Times
Fighting Frenchman shows us how as he ensures As...	30-Dec-2014	Daily Mail
Exclusive: UK firms vie for share of £170bn in A...	08-Dec-2014	The Independent

Latest AstraZeneca Director Deals

Traded	Action	Notifier	Price	Amount	Value
09-Sep-25	Buy	Karen Knudsen	11,983.78p	5	£599.19
14-Aug-25	Sell	Aradhana Sarin	11,511.70p	9,563	£1,100,863.84

More AstraZeneca director deals

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

AstraZeneca Market Data

Currency	UK Pounds
Share Price	12,454.00p
Change Today	18.00p
% Change	0.14 %
52 Week High	12,750.00
52 Week Low	9,667.00
Volume	2,710,473
Shares Issued	1,550.70m
Market Cap	£193,124m
RiskGrade	123